UnitedHealth Projects Growth Despite COVID Costs, Plus Tech Investment in 2021
At its annual investor day on Dec. 1, UnitedHealth Group predicted that it will incur $2 billion in extra, incidental expenditures in 2021 caused by the ongoing COVID-19 pandemic. Still, Wall Street analysts agreed with UnitedHealth executives’ overall bullish outlook, citing the payer-provider giant’s projected growth in Medicare Advantage (MA) enrollment and ongoing strong returns from its OptumHealth provider segment.
Citi analyst Ralph Giacobbe wrote in a Dec. 2 investor note that he was convinced by UnitedHealth executives’ assertions that COVID-19 held back projected 2021 revenue growth, and he anticipated “a higher baseline to consider when contemplating future years.”
Related Posts

Humana Anticipates Strong EPS Growth in 2023, Cites Individual MA Enrollment Increase
READ MORE
Study Could Help Policymakers Set Fair Reimbursement Rate for Ground Ambulances
READ MORE